Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2016
Period Ending	Dec 31, 2016
Net Income	-70.17M
Depreciation & Amortization	56.71M
Stock-Based Compensation	n/a
Other Working Capital	25.93M
Other Non-Cash Items	-3.63M
Deferred Income Tax	-943K
Change in Working Capital	36.24M
Operating Cash Flow	26.64M
Capital Expenditures	-51.43M
Cash Acquisitions	-142.02M
Purchase of Investments	-974K
Sales Maturities Of Investments	n/a
Other Investing Acitivies	-405K
Investing Cash Flow	-194.82M
Debt Repayment	n/a
Common Stock Repurchased	-974K
Dividend Paid	n/a
Other Financial Acitivies	170.84M
Financial Cash Flow	170.84M
Net Cash Flow	2.66M
Free Cash Flow	-24.79M